Primal Therapies, Inc. — Form D
Primal Therapies, Inc. of BOISE, ID, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-27. The offering totals $1.1M, of which $677K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-10-27
- Form: D
- Accession: 0001688401-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $677K
- Remaining: $400K
- Investors: 8
- Date of first sale: 2016-10-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273343
Issuer
- Name: Primal Therapies, Inc.
- CIK: 0001688401
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 9947 WEST EMERALD ST., BOISE, ID, 83704
- Phone: 510-847-8132
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Eigen | Director | Southport, CT |
| Terry Fadem | Director | BOISE, ID |
| Emily Stein | Director | BOISE, ID |
| Michael O'Donnell | Executive Officer | Dallas, TX |
| Emily Stein | Executive Officer | BOISE, ID |
More